EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study

Haiyan Ma iD, Haitao Zhu, Fangqing Chen, Yiqing Yang, Xuefeng Qu, Honghao Xu, Lu Yang iD, Rui Zhang iD

Epilepsia Open · 2023

DOI: 10.1002/epi4.12823 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Epilepsia Open, 2023. Verfasst von Haiyan Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Neurosurgery, Nanjing Brain Hospital affiliated to Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: East Asian People, Anticonvulsants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanjing Medical Science and Technology Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Efficacy and safety of perampanel monotherapy for treating focal‐onset seizures (FOS) has been barely studied in China. This observational study aimed to evaluate the efficacy and safety of perampanel monotherapy in treating Chinese patients with FOS.

Methods

This single‐center, prospective, real‐world observational study enrolled patients aged ≥4 years with FOS who visited the Epilepsy Out‐Patient Clinic of Nanjing Brain Hospital affiliated to Nanjing Medical University from January 2020 to December 2021. All patients were treated with perampanel monotherapy. Seizure‐freedom rates after 6 and 12 months of treatment were calculated. Adverse events (AEs) were recorded.

Results

Seventy patients with FOS were enrolled. The mean maintenance perampanel dose was 4.64 ± 1.55 mg/day. The 6‐ and 12‐month retention rates of perampanel monotherapy were 78.6% (55/70) and 70.0% (49/70), respectively. The 6‐ and 12‐month seizure‐freedom rates were 69.84% (44/63) and 65.08% (41/63), respectively. Patients with focal to bilateral tonic–clonic seizures had significantly higher 6‐month and numerically higher 12‐month seizure freedom rates than patients with focal impaired awareness seizures ( P = 0.046 and P = 0.204, respectively). Twenty‐six (37.1%) patients experienced treatment‐emergent AEs, and the most common AE was dizziness. Four (5.7%) patients withdrew from the study due to AEs. No new safety concern was observed. Significance This is the first prospective study on the efficacy and safety of perampanel monotherapy in treating Chinese patients with FOS, and perampanel monotherapy was effective and safe in treating Chinese patients aged ≥4 years with FOS up to 12 months. More multicenter, real‐world studies with large sample sizes and longer follow‐ups are needed to further evaluate the long‐term efficacy and safety of perampanel monotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

East Asian PeopleAnticonvulsantsHumansProspective StudiesTreatment OutcomeSeizuresOutpatientsNitrilesPyridones

Stichwörter der Autor:innen

Chinese patientsfocal to bilateral tonic-clonic seizuresfocal-onset seizuresperampanel monotherapyseizure-freedom rate

Substanzen

AnticonvulsantsperampanelNitrilesPyridones

Autor:innen und Institutionen

  • Department of Functional Neurosurgery, Nanjing Brain Hospital affiliated to Nanjing Medical University, Nanjing, China.

ORCID-Profile: Haiyan Ma, Lu Yang, Rui Zhang

Förderung

  • Nanjing Medical Science and Technology Development Project

Zitieren

APA

Ma, H., Zhu, H., Chen, F., Yang, Y., Qu, X., Xu, H., Yang, L., & Zhang, R. (2023). Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study. Epilepsia Open. https://doi.org/10.1002/epi4.12823

Vancouver

Ma H, Zhu H, Chen F, Yang Y, Qu X, Xu H, et al. Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study. Epilepsia Open. 2023. doi:10.1002/epi4.12823

BibTeX
@article{Ma2023,
  author = {Ma, Haiyan and Zhu, Haitao and Chen, Fangqing and Yang, Yiqing and Qu, Xuefeng and Xu, Honghao and Yang, Lu and Zhang, Rui},
  title = {Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study},
  journal = {Epilepsia Open},
  year = {2023},
  doi = {10.1002/epi4.12823}
}
Kostenlos starten →